Logan Health is celebrating its 100th atrial fibrillation procedure called Pulse Field Ablation, also known as PFA.This comes ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, ...

Pulse Biosciences has enrolled the first patient and completed the initial procedure in its NANOCLAMP AF Study, using its newly FDA-cleared nPulse Cardiac Surgical System to treat atrial fibrillation.

Pulse Biosciences, Inc, a novel bioelectric medicine company committed to health innovation and leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, has ...

- Company Expands Controlled Launch of the CellFX System into Canada Dr. Sheetal Sapra, a pioneer of modern dermatology technologies with a combined focus on medical, aesthetic, and clinical research, ...

A novel method uses bursts of nanosecond duration electric pulses to open the blood-brain barrier as a potential therapy for brain cancer and neurological disorders. The Vascular Enabled Integrated ...

There are numerous aesthetic procedures available in the market. But choosing the right one that suits your needs and fits the bill along with providing the desired is important. And a recent addition ...

- Company Expands Controlled Launch of the CellFX System into Canada HAYWARD, Calif., June 30, 2021--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company ...